GlassScriptPhysician profile
Alexander Hicks
NPI 1033643390
$1,895.64
in general payments reported to CMS, 2019-2025
17 companies · $913 in 2025
The $913 reported for 2025 was more than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $188 · 2023: $135 · 2024: $659 · 2025: $913.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,635 · Education: $72.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,635.20 |
| Education | $72.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $692.04 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $389.66 | 2022-2025 | |
| Janssen Biotech, INC. | $201.69 | 2023-2025 | Tremfya, Simponi, Simponi Aria |
| Incyte Corporation | $116.68 | 2022-2025 | Opzelura |
| Regeneron Healthcare Solutions, INC. | $76.70 | 2022-2025 | Dupixent |
| Leo Pharma INC. | $74.68 | 2024-2025 | Adbry, Anzupgo |
| Convatec INC. | $74.50 | 2025 | |
| Pfizer INC. | $42.16 | 2024 | |
| Lilly USA, LLC | $38.56 | 2023-2024 | Taltz |
| Ucb, INC. | $37.24 | 2024-2025 | Bimzelx |
| Genentech USA, INC. | $35.72 | 2022 | |
| Amgen INC. | $25.45 | 2022 | |
| Octapharma USA, INC. | $23.31 | 2022 | |
| Galderma Laboratories, L.P. | $22.97 | 2025 | Dysport |
| Arcutis Biotherapeutics, INC. | $17.83 | 2024 | Zoryve |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $14.48 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $11.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Hicks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.